Categories: Automobile

NEXEN TIRE Receives EcoVadis Gold Rating for Second Consecutive Year

  • Ranked among the top 3% globally for strengthened ESG management, with notable recognition in environmental and human rights practices

SEOUL, South Korea, Jul 14, 2025 – NEXEN TIRE, a leading global tire manufacturer, announced today that it has been awarded a Gold rating by EcoVadis, a globally recognized assessment platform, for the second year in a row. This distinction places that company among the top 3% of more than 150,000 companies evaluated worldwide.

- Advertisement -

Founded in France in 2007, EcoVadis assesses corporate sustainability performance across four key pillars: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement. Its ratings – Platinum (top 1%), Gold (top 5%), Silver (top 15%), and Bronze (top 35%) – are widely used benchmarks of ESG excellence.

- Advertisement -

NEXEN TIRE achieved strong, balanced improvements across all assessment areas, reflecting the company’s ongoing investment in ESG systems and practices.

- Advertisement -

In the Environment category, the company earned positive recognition for participating in global sustainability initiatives such as the Global Platform for Sustainable Natural Rubber (GPSNR), the UN Global Compact (UNGC), and the Science Based Targets initiative (SBTi). Notably, climate education programs and transparent disclosure of greenhouse gas emissions across all scopes were highlighted as key contributors.

- Advertisement -

In the Labor & Human Rights category, NEXEN TIRE was commended for aligning its human rights policy with international standards, including those set by the United Nations and the International Labour Organization (ILO). The company also introduced human rights assessments to bolster its risk management framework.

- Advertisement -

In the Ethics pillar, the company strengthened internal systems for risk prevention, monitoring, and mitigation, while the Sustainable Procurement score improved through ESG assessments, supplier audits, and proactive risk response strategies.

- Advertisement -

“Receiving the Gold rating from EcoVadis for the second consecutive year is a significant affirmation of our global ESG efforts,” said John Bosco (Hyeon Suk) Kim, CEO of NEXEN TIRE. “We remain committed to responsible and transparent management practices that meet the expectations of our stakeholders worldwide.”

- Advertisement -

This latest recognition underscores NEXEN TIRE’s long-term commitment to sustainable growth and its role as a responsible global corporate citizen.

- Advertisement -
TheNews Market

Recent Posts

Blockchain.com Unveils Highly Anticipated Crypto-Backed Loans, Bringing Borrowing To Crypto Holders Worldwide

The company launches in-house lending for global users starting at 1.9%, delivering one of the…

5 hours ago

Artmarket.com: The Artprice Manifesto: 22 Rules for a Regulated and Transparent Art Market in the Age of AI

Artificial intelligence is redistributing the value of information at an unprecedented pacePARIS, May 14, 2026…

5 hours ago

Crypto News: AlphaPepe Presale Records Surge in Whale Accumulation As Bitcoin Price Prediction Eyes $180,000

MONACO, May 16, 2026 (GLOBE NEWSWIRE) -- Crypto news is turning toward AlphaPepe after the…

14 hours ago

Crypto Market News: AlphaPepe Finalizes Tier-1 Exchange Shortlist as XRP Price Prediction Targets $5.00

MONACO, May 16, 2026 (GLOBE NEWSWIRE) -- Crypto market news is turning toward AlphaPepe after…

14 hours ago

Qoder Version 1.0 Released: Full Automation of Code Generation, Verification & Delivery

SINGAPORE, May 16, 2026 (GLOBE NEWSWIRE) -- Qoder officially releases version 1.0, upgrading from an…

14 hours ago

Ipsen presents first-in-class late-breaking Phase II corabotase data in glabellar lines showing sustained duration of effect reinforced by consistently high patient satisfaction

Patients treated with corabotase showed a rapid onset of action of 0.84 days and peak effect statistically superior to placeboAt Week 24, 60.8% of patients treated with corabotase experienced clinically…

14 hours ago